Patent classifications
C12N9/26
HYALURONIDASE COMPOSITIONS AND METHODS OF USING SAME TO TREAT FIBROSIS
The present disclosure provides a method of treating fibrosis in a subject in need thereof by administering a composition that comprises a protein having hyaluronidase activity to a region of the subject having fibrosis. Also provided are methods of reducing an amount or severity of fibrosis in a subject in need thereof comprising administering a composition that comprises a protein having hyaluronidase activity to a region of the subject having fibrosis, wherein the administration results in a reduction in a grade of severity of the fibrosis.
Alpha-amylase variants and polynucleotides encoding same
The present invention relates to variants of a parent alpha-amylase. The present invention also relates to polynucleotides encoding the variants and to nucleic acid constructs, vectors, and host cells comprising the polynucleotides, and methods of using the variant enzymes.
Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells
Genetically programmed microorganisms, such as bacteria or virus, pharmaceutical compositions thereof, and methods of modulating and treating cancers are disclosed.
Coatings containing polymer modified enzyme for stable self-cleaning of organic stains
Bioactive coatings that are stabilized against inactivation by weathering are provided including a base associated with a chemically modified enzyme, and, optionally a first polyoxyethylene present in the base and independent of the enzyme. The coatings are optionally overlayered onto a substrate to form an active coating facilitating the removal of organic stains or organic material from food, insects, or the environment.
METHODS FOR TREATING FARBER DISEASE
Methods of treating Farber disease using particular doses and pharmracokinetic profiles are disclosed.
SUBCUTANEOUS DELIVERY OF MESSENGER RNA
The present invention provides, among other things, methods of formulating nucleic acid-containing nanoparticles with an enzyme to afford efficient delivery of payload to a cell or tissue of interest via subcutaneous administration. In some embodiments, the present invention provides a process in which mRNA-loaded lipid nanoparticles are co-mixed with various amounts of hyaluronidase and administered via subcutaneous administration. The resulting payload can be efficiently delivered to the liver and other organs or tissues of a treated subject.
METHOD FOR PRODUCING MALTITOL, WITH AN INCREASED YIELD
A process for producing maltitol includes at least: producing a maltose syrup, by hydrolysis of a granular starch, in a first stage of liquefaction of granular starch to form a liquefied starch, followed by a stage of saccharification of the liquefied starch to which an aqueous solution of beta-amylase has been added, to form the maltose syrup; hydrogenating the maltose syrup to form an aqueous maltitol composition; and recovering the maltitol composition. The aqueous solution of beta-amylase also includes potassium sorbate, glycerol, and sodium carbonate.
METHOD FOR INCREASING OIL YIELD DURING ETHANOL PRODUCTION
A method for increasing the oil yield in an ethanol production process comprising: adding a liquid enzyme formulation having at least one enzyme, a buffering agent, a stabilizer, and a preservative wherein the pH of the enzyme formulation is about pH 6.0-8.0 to a beer, a distillation, a whole stillage, a centrifugation, a thin stillage, an evaporator, a syrup, or an oil recovery unit.
GLUCOSE PRODUCTION METHOD AND ETHANOL PRODUCTION METHOD
The present invention can: efficiently and readily produce glucose from microalgae that accumulate starch in their cells; and obtain ethanol. During a preparation step of the glucose production method, microalgae are prepared on which a saccharifying enzyme acts on starch accumulated inside the microalgae cells, without disrupting the cell walls. In a saccharification step, starch inside the cells is saccharified and glucose is generated, by adding a saccharifying enzyme to the microalgae without a disruption treatment. The ethanol production method has a step in which, after the saccharification step, the glucose undergoes alcoholic fermentation and ethanol is generated.
PROCESS OF ENZYMATIC DEGRADATION OF AN ABSORBENT STRUCTURE FOR A HYGIENE ARTICLE
The present invention relates to a process of enzymatic degradation of an absorbent structure, the absorbent structure being suitable for providing an absorbent core of a hygiene article, wherein the process comprises the step of contacting the absorbent structure with a solution comprising enzymes; wherein the absorbent structure comprises a polysaccharide superabsorbent polymer, such as a cellulose-based or a starch-based superabsorbent polymer.